Impaired first‐phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes

References

• Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 1999; 354: 617–21
   PubMed Web of Science ®Google Scholar
• Donahue R. P., Abbott R. D., Reed D. M., Yano K. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program. Diabetes 1987; 36: 689–92
   PubMed Web of Science ®Google Scholar
• Meigs J. B., Nathan D. M., D'Agostino R. B Sr., Wilson P. W. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002; 25: 1845–50
   PubMed Web of Science ®Google Scholar
• Ceriello A., Bortolotti N., Motz E., et al. Meal‐generated oxidative stress in type 2 diabetic patients. Diabetes Care 1998; 21: 1529–33
   PubMed Web of Science ®Google Scholar
• Ceriello A., Cavarape A., Martinelli L., et al. The post‐prandial state in type 2 diabetes and endothelial dysfunction: effects of insulin aspart. Diabet Med 2004; 21: 171–5
   PubMed Web of Science ®Google Scholar
• Nishikawa T., Edelstein D., Du X. L., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000; 404: 787–90
   PubMed Web of Science ®Google Scholar
• Del Prato S., Tiengo A. The importance of first‐phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab Res Rev 2001; 17: 164–74
   PubMed Web of Science ®Google Scholar
• Bruttomesso D., Pianta A., Mari A., et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes 1999; 48: 99–105
   PubMed Web of Science ®Google Scholar
• Del Prato S. Loss of early insulin secretion leads to postprandial hyperglycaemia. Diabetologia 2003; 46 Suppl 1: M2–8
   Google Scholar
• Weyer C., Bogardus C., Mott D. M., Pratley R. E. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999; 104: 787–94
   PubMed Web of Science ®Google Scholar
• Turner R. C., Mathews D. R., Holman R. R., Peto J. Relative contributions of insulin deficiency and insulin resistance in maturity‐onset diabetes. Lancet 1982; 1: 596–8
   PubMedGoogle Scholar
• Mitrakou A. Pathogenesis of hyperglycaemia in type 2 diabetes. Diabetes Obes Metab 2002; 4: 249–54
   PubMedGoogle Scholar
• Bergman R. N., Finegood D. T., Kahn S. E. The evolution of beta‐cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 2002; 32 Suppl 3: 35–45
   PubMedGoogle Scholar
• Leahy J. L. Pathogenesis of type 2 diabetes mellitus. Arch Med Res 2005; 36: 197–209
   PubMed Web of Science ®Google Scholar
• Scheen A. J., Castillo M. J., Lefebvre P. J. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications. Diabetes Metab 1996; 22: 397–406
   PubMedGoogle Scholar
• Matthews D. R., Hosker J. P., Rudenski A. S., et al. Homeostasis model assessment – insulin resistance and beta‐cell function from fasting plasma‐glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–19
   PubMed Web of Science ®Google Scholar
• Owens D. R., Dolben J., Jones I. R., Birtwell J., Luzio S. D. Hormonal and glycaemic responses to serial meals in newly diagnosed non‐insulin dependent diabetic patients. Diabetes Metab 1989; 15: 1–4
   Google Scholar
• DeFronzo R. A., Bonadonna R. C., Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992; 15: 318–68
   PubMed Web of Science ®Google Scholar
• Kahn S. E. Clinical review 135: The importance of beta‐cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001; 86: 4047–58
   PubMed Web of Science ®Google Scholar
• Hales C. N. The pathogenesis of NIDDM. Diabetologia 1994; 37(Suppl 2)S162–8
   Google Scholar
• Godsland I. F., Jeffs J. A., Johnston D. G. Loss of beta cell function as fasting glucose increases in the non‐diabetic range. Diabetologia 2004; 47: 1157–66
   PubMed Web of Science ®Google Scholar
• Albarrak A. I., Luzio S. D., Chassin L. J., et al. Associations of glucose control with insulin sensitivity and pancreatic beta‐cell responsiveness in newly presenting type 2 diabetes. J Clin Endocrinol Metab 2002; 87: 198–203
   PubMedGoogle Scholar
• Monnier L., Lapinski H., Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 2003; 26: 881–5
   PubMed Web of Science ®Google Scholar
• Bonora E., Calcaterra F., Lombardi S., et al. Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care 2001; 24: 2023–9
   PubMed Web of Science ®Google Scholar
• Park S. W., Ihm S. H., Yoo H. J., Park J. Y., Lee K. U. Differential effects of ambient blood glucose level and degree of obesity on basal serum C‐peptide level and the C‐peptide response to glucose and glucagon in non‐insulin‐dependent diabetes mellitus. Diabetes Res Clin Pract 1997; 37: 165–71
   PubMed Web of Science ®Google Scholar
• Yoneda H., Ikegami H., Yamamoto Y., et al. Analysis of early‐phase insulin responses in nonobese subjects with mild glucose intolerance. Diabetes Care 1992; 15: 1517–21
   PubMed Web of Science ®Google Scholar
• Iwasaki Y., Kondo K., Hasegawa H., Oiso Y. C‐peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test. Diabetes Res 1994; 25: 129–37
   PubMedGoogle Scholar
• Leahy J. L., Bonner‐Weir S., Weir G. C. Beta‐cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose‐induced insulin secretion. Diabetes Care 1992; 15: 442–55
   PubMed Web of Science ®Google Scholar